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Angelman syndrome (AS) is a neurodevelopmental disorder presented by jerky 
movement, speech delay and cognitive disability epilepsy as well as dysmorphic 
features. It occurs due to an expression deletion in 15q11-q13 chromosome.  In 
this article, we present an eight yr boy referred to Pediatrics Neurologic Clinic 
Mashhad, Iran for speech delay. He had abnormal behavior ataxia unusual 
laughing facial expression intellectual disability and mandibular prognathism. 
Metabolic screening tests and brain MRI were normal. Genetic analysis was 
pathognomonic for AS.
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Introduction
Angelman syndrome (AS) was first described in 1965 by Harry Angelman (1). 
He reported 3 children of healthy parents with neurologic syndrome of mental 
retardation, seizure, facial abnormalities, ataxia, speech disorders and unprovoked 
laugh pattern.  He named them happy puppet. The name of this syndrome changed 
into AS in 1987 (2). Its genetic base was identified in 1987 (2). 
AS is originated from dysfunction in expression of ubiquitin protein ligase E3A 
(UBE3A) gene in chromosome 15 (3). In 75% of cases a deletion happens in this 
chromosome, other changes such as translocation, mutation and micro-deletion are 
seen as well (4). These changes lead to malfunction of neurons. AS incidence is 
estimated 1 in 15000 live births, and recently nearly 450 cases of AS have been 
reported (5).
This neurodevelopmental syndrome occurs because of maternally inherited genes. 
Disease manifestations are language deficit, laughing facial expression, autistic 
or stereotyped behavior, jerky ataxia and severe mental retardation. Patients have 
communicative disability with or without seizure (3). These children also have 
cognitive disorders. 
Here we describe a child with AS.
Case report 
An 8 yr old boy was referred to Pediatrics Neurologic Clinic Mashhad, Iran; due to 
developmental delay and seizure attacks from 6 yr ago. He was the second child of 
non relative healthy parents; there was no evidence of seizure or mental retardation 
in his family. He was born at term by a vaginal delivery with normal APGAR score 
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and birth weight. He had a history of neonatal icterus 
and phototherapy. 
He had a happy face and the parents noticed 
developmental delay at 2 yr old. He was admitted in a 
hospital because of tonic-colonic seizures and valproate 
sodium was administered for him. He was able to walk 
independently at 4 yr old. At the age of 6 yr, he was 
referred to Children Neurology Department in Mashhad 
due to hyperactivity, where received risperidone. 
On physical examination, he had mandibular 
prognathism, strabismus and unusual laughing facial 
expression (Figure1). His head circumference was 51 
cm.
Written informed consent was obtained from his 
parents. 
 
Fig 1: facial expression of Angelman syndrome
His walking was unsteady, but muscles tone, force 
and deep tendon reflexes were normal. Joints range of 
motion was normal. Besides, he had speech disability 
and could walk independently, but could not run. He 
had restricted communicative abilities and suffered 
from severe mental retardation. 
Laboratory findings were normal. Brain MRI and 
CBC test were normal. Thyroid function test showed 
hypothyroidism, controlled by levothyroxine since 2 yr 
old.
In our patient, seizure attacks have been continued 
from the age of 2 yr, despite various pharmacologic 
treatments.
Genetic findings
After genomic DNA extraction, the DNAs were treated 
by bisulfide method and methylation specific PCR for the 
SRNP region were used. Genomic DNA was extracted 
from leukocytes collected in EDTA tubes (5PRIME kit 
GmbH, D-22767 Hamburg). The genomic DNA was 
treated by the Na bisulfit (So2) (Sigma) method. After 
treatment the methylation specific PCR was used. 
The previously described primers, MAT: 5’-tat tgc ggt 
aaa taa gta cgt ttg cgc ggt c-3’
PAT: 5’-gtg agt ttg gtg tag agt gga gtg gtt gtt g-3’ 
COM: 5’-ctc caa aac aaa aaa ctt taa aac cca aat tcc-3’ 
were used to amplify the region.
Genomic treated DNA (300 ng) was used as template in 
a reaction volume of 23 μL, containing 10.8 μl ddH2O, 
2.5 μl 10X reaction buffer, 25 mM MgCl2, and 10 
mM dNTP, 5mM of each primer and 5U of Taq DNA 
polymerase (Genet Bio). Cycling conditions were 94 °C 
for 5 min, followed by 35 cycles of 25 sec at 94 °C, 25 
sec at 60 °C and 25 sec at 72 °C, and 5 min at 72 °C as 
the final extension step. For the positive controlled of 
methylation test, we used the p16 gene. 
For this patient abnormal methylation pattern of the 
SRNP region (Maternal imprinting defects or deletion) 
was detected. Therefore, an AS caused by micro 
deletion, uniparental disomie or imprinting defect (ID) 
was included. ID defect account for approximaly 3% of 
affected individual. ID have abnormal DNA methylation 
and 10-20% of the ID are caused by micro deletion (6-
200kb) that include the imprinting Center (Figure 2). 
  
Discussion 
Many cases of AS have impaired communication, 
which might occur due to language deficit and mental 
retardation (9). Our patient had this problem. 
Delayed motor development is common in AS, jerky 
movements are the first manifestation of AS, recognize 
by parents (10). In our reported case, developmental 
delayed was identified by parents at the age of 2 yr. 
Several facial abnormalities were reported in AS patients 
such as wide mouth, abnormal teeth, tongue protrusion 
and mandibular prognathism. There are some evidence 
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on poor sucking and chewing in infancy (11). Our case 
had a wide mouth with unusual laughing lips, which is 
common in AS. 
Around 70% of AS children could walk at 3 yr old (12), 
our caes could walk independently when he was 4 yr, 
but he still cannot run at 8.
Electroencephalography findings were abnormal in AS 
patient and EEG showed generalized spike and wave 
pattern (6). Over 855 of AS patients develop seizure in 
the first 3 yr of life. Its onset varies from 1 month to 20 
years (7). Epilepsy is severe in AS cases and is hard to 
control as our case. It seems that valproic acid is the 
therapeutic choice in AS epilepsy (8). 
Genetic tests for diagnosing AS are complex analysis. 
A small proportion of patients with AS may have a 
small deletion or other mutations that leads to aberrant 
imprinting of the region (13). These findings have 
led to major advances in genetic diagnosis of AS. 
Chromosome 15 deletions usually are submicroscopic 
but are easily detected by FISH and/or array CGH. 
Defects in imprinting or uniparental disomy can be 
identified by studies of patterns of DNA methylation 
in the region. Failure to identify the methylated or 
nonmethylated copy of the sequence is indicative 
of deletion, uniparental disomy, or a mutation that 
alters the imprinting mechanism. Genomic imprints 
are reversible and lead to differential expression in 
the course of development. Genomic imprinting is 
an epigenetic process that involves methylation and 
histone modifications in order to achieve monoallelic 
gene expression without altering the genetic sequence 
(14).
In conclusion, all physicians should consider rare 
syndromes such as AS in children or adults with 
neurodevelopmental delay. Noting clinical presentation 
is very important, because clinical suspicions play a 
crucial role to choose the required laboratory tests. On 
the other hand, multidiscipline approach is necessary 
for genetic syndromes like AS because they influence 
all aspects of patients’ life.
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